Fate Therapeutics Inc (FATE)

59.27 +1.11  +1.91% NASDAQ Oct 26, 16:00 59.27 0.00  0.00% After-Hours: 19:51 USD
View Full Chart
Price Chart
View All FATE News

News

View All Events

Events

Date Type Description
11/05/2021 Earnings Results Q3 2021 Earnings Results
11/05/2021 17:00 EST Earnings Calls Q3 2021 Earnings Call
08/04/2021 Earnings Results Q2 2021 Earnings Results
08/04/2021 17:00 EST Earnings Calls Q2 2021 Earnings Call
06/02/2021 11:00 EST AGM 2020 Annual General Meeting
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 17:00 EST Earnings Calls Q1 2021 Earnings Call
02/24/2021 Earnings Results Q4 2020 Earnings Results
02/24/2021 17:00 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 17:00 EST Earnings Calls Q3 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
  • URL: http://www.fatetherapeutics.com
  • Investor Relations URL: https://ir.fatetherapeutics.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 05, 2021
  • Last Earnings Release: Aug. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
EAGB.NO Emerge ARK Genomics & Biotech ETF 3.96%
ARKG ARK Genomic Revolution ETF 3.92%
IDNA iShares Genomics Immnlgy & Hlthcr ETF 3.08%
CNCR Loncar Cancer Immunotherapy ETF 2.41%
EARK.NO Emerge ARK Global Disruptive Innovt ETF 1.76%
JRJUX JPMorgan Small Cap Sustainable Ldrs R2 1.74%
ARKK ARK Innovation ETF 1.72%
NBMVX Neuberger Berman Small Cap Growth Adv 1.59%
LAUCX Columbia Acorn USA C 1.58%
BRUFX Bruce 0.91%
ASMNX AQR Small Cap Momentum Style N 0.51%
FSSNX Fidelity® Small Cap Index 0.23%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.